Shock Wave
Shock Wave, licence 80053936: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- PHP Shockwave
- Licence holder
- Konsar Future Nutrition Inc.
- NPN or DIN-HM
- 80053936
- Status
- Inactive licence
- Licence date
- 16 September 2014
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-méthyl-N-guanylglycine Source : Chlorhydrate d'ester d'éthyle de créatine | 750.0 mg | Not calculated |
| Acide bêta-aminopropionique Source : Beta-alanine | 750.0 mg | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 200.0 mg | Not calculated |
| L-arginine Source : Alpha-cétoglutarate de L-arginine | 1500.0 mg | Not calculated |
| (S)-N5-Carbamoylornithine Source : Malate de citrulline | 500.0 mg | Not calculated |
| Acide (S)-2,5-diaminopentanoïque Source : L-Ornithine | 750.0 mg | Not calculated |
| Acide (S)-2,5-diaminopentanoïque Source : Zea mays - Feuille | 750.0 mg | Not calculated |
| Glycine, N-(aminoiminométhyl)-N-méthyl-, monohydrochlorure Source : Chlorhydrate de créatine | 750.0 mg | Not calculated |
| L-norvaline Source : L-norvaline | 1.0 mg | Not calculated |
| Acide aminoacétique Source : Glycine | 500.0 mg | Not calculated |
| 1,3,7-Triméthylxanthine Source : Caféine | 200.0 mg | Not calculated |
| 4-hydroxy-alpha-[(méthylamino)méthyl]benzèneméthanol Source : Synephrine hydrochloride | 20.0 mg | Not calculated |
| 4-hydroxy-alpha-[(méthylamino)méthyl]benzèneméthanol Source : Citrus aurantifolia - Pelure (fruit) | 20.0 mg | Not calculated |
| L-Tyrosine Source : N-acétyltyrosine | 50.0 mg | Not calculated |
Non-medicinal ingredients
Acide DL-malique, Gomme de xanthane, Acesulfame-K, triglycérides à chaînes moyennes, Acid citrique, Saveur d'orange, Carraghénine, Sucralose, Dioxyde de silicium, bêta-carotène
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Mesures | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Workout supplement. Atheletic support.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80053936
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.